INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - What is the rationale in combining these agents together? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #...

INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - What is the rationale in combining these agents together? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #...

User Photo
Cancer-News

1 month
8 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David A. Reardon, MD Dana-Farber Cancer Institute discusses What is the rationale in combining these agents together? - INO-5401 and INO-9012 in combination with cemiplimab REGN2810 in newly diagnosed glioblastoma GBM Interim results.
Up Next Autoplay